10651 related articles for article (PubMed ID: 10026893)
1. Adenovirus-mediated ex vivo immunogene and in vivo combination gene therapy strategies induce a systemic anti-tumor immune defense in the mouse B16 melanoma model.
Bonnekoh B; Greenhalgh DA; Chen SH; Bickenbach J; Block A; Rich SS; Krieg T; Woo SL; Roop DR
Adv Exp Med Biol; 1998; 451():335-43. PubMed ID: 10026893
[No Abstract] [Full Text] [Related]
2. Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model.
Bonnekoh B; Greenhalgh DA; Chen SH; Block A; Rich SS; Krieg T; Woo SL; Roop DR
J Invest Dermatol; 1998 Jun; 110(6):867-71. PubMed ID: 9620291
[TBL] [Abstract][Full Text] [Related]
3. A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model.
Castleden SA; Chong H; Garcia-Ribas I; Melcher AA; Hutchinson G; Roberts B; Hart IR; Vile RG
Hum Gene Ther; 1997 Nov; 8(17):2087-102. PubMed ID: 9414257
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
Mizuguchi H; Hayakawa T
Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
[TBL] [Abstract][Full Text] [Related]
5. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus-thymidine kinase and granulocyte macrophage-colony stimulating factor genes in murine colon cancer.
Hayashi S; Emi N; Yokoyama I; Namii Y; Uchida K; Takagi H
Cancer Gene Ther; 1997; 4(6):339-44. PubMed ID: 9408603
[TBL] [Abstract][Full Text] [Related]
7. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.
Vile RG; Nelson JA; Castleden S; Chong H; Hart IR
Cancer Res; 1994 Dec; 54(23):6228-34. PubMed ID: 7954471
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus.
Siders WM; Halloran PJ; Fenton RG
Cancer Gene Ther; 1998; 5(5):281-91. PubMed ID: 9824047
[TBL] [Abstract][Full Text] [Related]
9. Gene marking and gene therapy in multiple myeloma.
Gahrton G; Björkstrand B; Dilber MS; Sundman-Engberg B; Ljungman P; Smith CI
Adv Exp Med Biol; 1998; 451():493-7. PubMed ID: 10026917
[No Abstract] [Full Text] [Related]
10. A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients.
Alvarez RD; Curiel DT
Hum Gene Ther; 1997 Mar; 8(5):597-613. PubMed ID: 9095411
[No Abstract] [Full Text] [Related]
11. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
[TBL] [Abstract][Full Text] [Related]
13. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
14. Cell-specific induction of sensitivity to ganciclovir in medullary thyroid carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase.
Minemura K; Takeda T; Minemura K; Nagasawa T; Zhang R; Leopardi R; DeGroot LJ
Endocrinology; 2000 May; 141(5):1814-22. PubMed ID: 10803592
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.
O'Malley BW; Chen SH; Schwartz MR; Woo SL
Cancer Res; 1995 Mar; 55(5):1080-5. PubMed ID: 7866992
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal gene therapy for malignant leptomeningeal neoplasia.
Ram Z; Walbridge S; Oshiro EM; Viola JJ; Chiang Y; Mueller SN; Blaese RM; Oldfield EH
Cancer Res; 1994 Apr; 54(8):2141-5. PubMed ID: 8174120
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer.
Miller PW; Sharma S; Stolina M; Chen K; Zhu L; Paul RW; Dubinett SM
Cancer Gene Ther; 1998; 5(6):380-9. PubMed ID: 9917093
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir.
Wang S; Qi J; Smith M; Link CJ
Cancer Gene Ther; 2002 Jan; 9(1):1-8. PubMed ID: 11916238
[TBL] [Abstract][Full Text] [Related]
19. Increased anti-tumor effect by a combination of HSV thymidine kinase suicide gene therapy and interferon-gamma/GM-CSF cytokine gene therapy in CT26 tumor model.
Yang SH; Oh TK; Kim ST
J Korean Med Sci; 2005 Dec; 20(6):932-7. PubMed ID: 16361799
[TBL] [Abstract][Full Text] [Related]
20. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.
Kanazawa T; Mizukami H; Okada T; Hanazono Y; Kume A; Nishino H; Takeuchi K; Kitamura K; Ichimura K; Ozawa K
Gene Ther; 2003 Jan; 10(1):51-8. PubMed ID: 12525837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
